The iron chelator deferoxamine decreases myeloma cell survival.
The iron chelator deferoxamine decreases myeloma cell survival.
复制标题
DOI:
10.1177/0300060520987396
复制
发表时间:
2021-01
期刊:
影响因子:
--
通讯作者:
Xu Y
中科院分区:
文献类型:
--
作者:
Yang F;Wu Z;Dai D;Zhang L;Zhang X;Zhang X;Xu Y
This study evaluated serum ferritin (SF) levels and investigated their relationships with various clinical markers in patients with multiple myeloma (MM). Furthermore, the effects and molecular mechanism of deferoxamine (DFO) in myeloma cells were studied. Clinical data from 84 patients with MM were collected to evaluate SF content and its relationship with several important clinical parameters. MM1S and MM1R myeloma cells were chosen to investigate the effects of iron and DFO on cell survival and apoptosis. Increased SF levels were detected in newly diagnosed patients, especially those with stage III disease or the κ isotype. SF content was positively correlated with β2-microglobulin, interleukin-6, and lactate dehydrogenase expression. Furthermore, patients with progressive or relapsed disease had higher SF levels. Importantly, iron chelation with DFO efficiently inhibited myeloma cell survival and accelerated apoptosis by regulating apoptosis-related genes. The importance of SF for MM was highlighted. Additionally, it is suggested that DFO may be a good therapeutic option for MM.
登录
查看更多内容
影响因子:
2.6
作者:
Benadiba, Joy;Rosilio, Celia;Peyron, Jean-Francois
通讯作者:
Peyron, Jean-Francois
影响因子:
4.8
作者:
Shouval, Roni;Teper, Omer;Shimoni, Avichai
通讯作者:
Shimoni, Avichai
影响因子:
3.8
作者:
Shan Z;Wei Z;Shaikh ZA
通讯作者:
Shaikh ZA
影响因子:
4
作者:
Jin, Yanxia;Shang, Yufeng;Zhou, Fuling
通讯作者:
Zhou, Fuling
影响因子:
11.2
作者:
Gu Z;Wang H;Xia J;Yang Y;Jin Z;Xu H;Shi J;De Domenico I;Tricot G;Zhan F
通讯作者:
Zhan F